References
- Freedman SA, Reshef S, Weiniger CF. Post-traumatic stress disorder and postpartum depression and their reported association with recent labor and delivery: a questionnaire survey cohort. Int J Obstet Anesth. 2020;43:18–24.
- Wenzel ES, Pinna G, Eisenlohr-Moul T, et al. Neuroactive steroids and depression in early pregnancy. Psychoneuroendocrinology. 2021;134:105424.
- Brunton PJ, Russell JA. The expectant brain: adapting for motherhood. Nat Rev Neurosci. 2008;9(1):11–25.
- Salazar de Pablo G, Solmi M, Vaquerizo-Serrano J, et al. Primary prevention of depression: an umbrella review of controlled interventions. J Affect Disord. 2021;294:957–970.
- Ramsteijn AS, Jasarevic E, Houwing DJ, et al. Antidepressant treatment with fluoxetine during pregnancy and lactation modulates the gut microbiome and metabolome in a rat model relevant to depression. Gut Microbes. 2020;11(4):735–753.
- Unroe KA, Glover ME, Shupe EA, et al. Perinatal SSRI exposure disrupts G protein-coupled receptor BAI3 in developing dentate gyrus and adult emotional behavior: relevance to psychiatric disorders. Neuroscience. 2021;471:32–50.
- Millard SJ, Lum JS, Fernandez F, et al. Perinatal exposure to fluoxetine increases anxiety- and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent rats: a comparison between Sprague-Dawley rats and the Wistar-Kyoto rat model of depression. J Psychopharmacol. 2019;33(2):230–243.
- Jovcevska I, Videtic Paska A. Neuroepigenetics of psychiatric disorders: focus on lncRNA. Neurochem Int. 2021;149:105140.
- Bella F, Campo S. Long non-coding RNAs and their involvement in bipolar disorders. Gene. 2021;796-797:145803.
- Huan Z, Mei Z, Na H, et al. lncRNA MIR155HG alleviates depression-like behaviors in mice by regulating the miR-155/BDNF axis. Neurochem Res. 2021;46(4):935–944.
- Wang L, Zhang M, Zhu H, et al. Combined identification of lncRNA NONHSAG004550 and NONHSAT125420 as a potential diagnostic biomarker of perinatal depression. J Clin Lab Anal. 2021;35(8):e23890.
- Liu S, Zhou B, Wang L, et al. Therapeutic antidepressant potential of NONHSAG045500 in regulating serotonin transporter in major depressive disorder. Med Sci Monit. 2018;24:4465–4473.
- Wang C, Guo J, Guo R. Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stress. BMC Complement Altern Med. 2017;17(1):73.
- Chang B, Liu Y, Hu J, et al. Bupleurum Chinense DC improves CUMS-induced depressive symptoms in rats through upregulation of the cAMP/PKA/CREB signalling pathway. J Ethnopharmacol. 2022;289:115034.
- Li XY, Qi WW, Zhang YX, et al. Helicid ameliorates learning and cognitive ability and activities cAMP/PKA/CREB signaling in chronic unpredictable mild stress rats. Biol Pharm Bull. 2019;42(7):1146–1154.
- Duman CH, Schlesinger L, Kodama M, et al. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry. 2007;61(5):661–670.
- Xiang D, Sun S, Wang G, et al. Effects of CRMP2 DNA methylation in the hippocampus on depressive-like behaviors and cytoskeletal proteins in rats. Front Cell Neurosci. 2021;15:644663.
- Gemmel M, Harmeyer D, Bogi E, et al. Perinatal fluoxetine increases hippocampal neurogenesis and reverses the lasting effects of pre-gestational stress on serum corticosterone, but not on maternal behavior, in the rat dam. Behav Brain Res. 2018;339:222–231.
- Kiryanova V, Meunier SJ, Dyck RH. Behavioural outcomes of adult female offspring following maternal stress and perinatal fluoxetine exposure. Behav Brain Res. 2017;331:84–91.
- Kiryanova V, Meunier SJ, Vecchiarelli HA, et al. Effects of maternal stress and perinatal fluoxetine exposure on behavioral outcomes of adult male offspring. Neuroscience. 2016;320:281–296.
- Xu H, Liu C, Rao S, et al. LncRNA NONRATT021972 siRNA rescued decreased heart rate variability in diabetic rats in superior cervical ganglia. Auton Neurosci. 2016;201:1–7.
- Zepeda-Quiroz N, Luna-Reséndiz R, Soto-Sánchez J. Efficacy of individualized homeopathy in treatment-resistant depression. Cureus. 2021;13(10):e18444.
- Vestring S, Serchov T, Normann C. Animal models of depression – chronic despair model (CDM). J Vis Exp. 2021;(175). DOI:10.3791/62579
- Wang Q, Timberlake MA, Prall K, et al. The recent progress in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry. 2017;77:99–109.
- Nemoda Z, Massart R, Suderman M, et al. Maternal depression is associated with DNA methylation changes in cord blood T lymphocytes and adult hippocampi. Transl Psychiatry. 2015;5(4):e545.
- Wei W, Wang ZY, Ma LN, et al. MicroRNAs in alzheimer’s disease: function and potential applications as diagnostic biomarkers. Front Mol Neurosci. 2020;13:160.
- Wan Y, Liu Y, Wang X, et al. Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder. PLOS One. 2015;10(3):e0121975.
- Meseure D, Drak Alsibai K, Nicolas A, et al. Long noncoding RNAs as new architects in cancer epigenetics, prognostic biomarkers, and potential therapeutic targets. Biomed Res Int. 2015;2015:320214.
- Kaur P, Liu F, Tan JR, et al. Non-coding RNAs as potential neuroprotectants against ischemic brain injury. Brain Sci. 2013;3(1):360–395.
- Cui X, Sun X, Niu W, et al. Long non-coding RNA: potential diagnostic and therapeutic biomarker for major depressive disorder. Med Sci Monit. 2016;22:5240–5248.
- Overgaard A, Lieblich SE, Richardson R, et al. Paroxetine blunts the corticosterone response to swim-induced stress and increases depressive-like behavior in a rat model of postpartum depression. Psychoneuroendocrinology. 2018;89:223–228.
- Seth S, Lewis AJ, Galbally M. Perinatal maternal depression and cortisol function in pregnancy and the postpartum period: a systematic literature review. BMC Pregnancy Childbirth. 2016;16(1):124.
- Guintivano J, Arad M, Gould TD, et al. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry. 2014;19(5):560–567.
- Ślifirski G, Król M, Turło J. 5-HT receptors and the development of new antidepressants. IJMS. 2021;22(16):9015.
- Birnbaumer L. Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers. Biochim Biophys Acta. 2007;1768(4):772–793.
- Kim MH, Leem YH. Chronic exercise improves repeated restraint stress-induced anxiety and depression through 5HT1A receptor and cAMP signaling in hippocampus. J Exerc Nutrition Biochem. 2014;18(1):97–104.
- Zhao L, Guo R, Cao N. An integrative pharmacology-based pattern to uncover the pharmacological mechanism of ginsenoside H dripping pills in the treatment of depression. Front Pharmacol. 2020;11:590457.
- Peng Y, Zhang C, Su Y, et al. Activation of the hippocampal AC-cAMP-PKA-CREB-BDNF signaling pathway using WTKYR in depression model rats. Electrophoresis. 2019;40(8):1245–1250.
- Hao Y, Ge H, Sun M, et al. Selecting an appropriate animal model of depression. Int J Mol Sci. 2019;20(19):4827.